Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
That is remarkably compact
Tirzepatide Tirzepatide (LY3298176) is a synthetic dual agonist at the GIP and GLP-1 receptors, supplied as a pre-loaded multi-dose injector pen for research and laboratory use only
The evidence is clear
These dates are backed by extensive stability studies conducted by Novo Nordisk, the manufacturer
It is described as a triple hormone receptor agonist, meaning it activates: GLP-1 receptors GIP receptors Glucagon receptors This differentiates it from currently approved therapies such as: Wegovy (GLP-1 only) Mounjaro (GLP-1 + GIP) Retatrutide adds glucagon receptor activation, creating a triple-pathway metabolic effect
Ideally, future research with obesity management medications will include direct measures of physical function
US$ 20.29
US$ 26.18
US$ 20.71
US$ 24.05
US$ 28.11
US$ 24.74
US$ 22.42
